1) Palinavir
帕利那韦
2) ritonavir
利托那韦
1.
Pharmacokinetics Study of Ritonavir in Chinese Healthy Volunteers;
利托那韦在国人体内的药代动力学研究
2.
Synthetic Study of Intermediates for Anti-Aids Drug-Ritonavir;
抗艾滋病药物—利托那韦中间体的合成研究
3.
Stavudine and Ritonavir are effective therapeutic agents for the treatmentof AIDS.
司它夫定(Stavudine)和利托那韦(Ritonavir)是FDA正式批准的治疗艾滋病的高效抗逆转录病毒治疗(HAART)药物。
3) Telinavir
替利那韦
4) ritonavir solution
利托那韦口服液
1.
Pharmacokinetics and bioequivalence of ritonavir solutions in healthy volunteers;
利托那韦口服液在健康人体的药代动力学和生物等效性
5) Wipha
韦帕
1.
The weather dynamic diagnosis of rainstorm caused by 200713 typhoon Wipha was analyzed.
对200713号台风"韦帕"造成的暴雨进行了天气动力学诊断分析。
2.
When typhoon Wipha passed through Jiangsu in Septemper 2007,the 3-dimensional strong wind data was wholly recorded by the anemometer.
2007年9月台风"韦帕"袭击江苏东部时,风速仪记录了经过该桥南塔塔顶的三维强风样本。
6) peramivir
帕拉米韦
1.
Quantification of peramivir in rat plasma by liquid chromatography/tandem mass spectrometry employing precolumn derivatization and its application in pharmacokinetics
衍生化LC-MS/MS测定大鼠血浆中新型抗流感药物帕拉米韦及其在药代动力学研究中的应用
2.
This review summarizes the research advances of peramivir on the mechanism of action,pharmacodynamics,pharmacokinetics,clinical studies and side effects.
帕拉米韦(Peram ivir)是一种以流感病毒表面糖蛋白神经氨酸酶为作用靶点的新型环戊烷类抗流感药物。
3.
Methods Peramivir was synthesized with 2-azabicyclo[2,2,1]hept-5-en-3-one and 2-ethyl butylaldehyde as starting materials and through multi-steps reactions including amide hydrolysis,amino group protection and addition reaction.
目的改进神经氨酸酶抑制剂帕拉米韦合成方法,提高其反应收率,确定其对人工感染禽流感病毒小鼠的防治效果、适宜剂量及给药方式。
补充资料：利托那韦
分子式：C37H48N6O5S2
分子量：720.94
CAS号：155213-67-5
性质：暂无
制备方法：暂无
用途：暂无
分子量：720.94
CAS号：155213-67-5
性质：暂无
制备方法：暂无
用途：暂无
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条